Proteasome inhibitor‐associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature-Reference-Cited by-同舟云学术

Proteasome inhibitor‐associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature

Published:2020-04-29 Issue:9 Volume:95 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Nguyen Michelle Nadeau¹^ORCID,Nayernama Afrouz¹,Jones S. Christopher¹,Kanapuru Bindu²,Gormley Nicole²,Waldron Peter E.¹

Affiliation:

1. Division of Pharmacovigilance Office of Surveillance and Epidemiology, U.S. Food and Drug Administration Silver Spring Maryland USA

2. Division of Hematologic Malignancies Office of Oncologic Diseases, U.S. Food and Drug Administration Silver Spring Maryland USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25832

Reference10 articles.

1. Millennium Pharmaceuticals Inc. Velcade product monograph 2019.https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7.

2. Millennium Pharmaceuticals Inc. Ninlaro product monograph 2020.https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=038f2461-834b-4488-9ebd-863c83eef5a7.

3. Onyx Pharmaceuticals Inc. Kyprolis product monograph 2019.https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ea66eb30-e665-4693-99a1-a9d3b4bbe2d6.

4. Syndromes of Thrombotic Microangiopathy

5. Drug-induced thrombotic microangiopathy: Experience of the Oklahoma registry and the BloodCenter of Wisconsin

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomes;Nephrology Dialysis Transplantation;2024-04-24

2. Organoboronic acids/esters as effective drug and prodrug candidates in cancer treatments: challenge and hope;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-06-15

3. Chemotherapy-Associated Thrombotic Microangiopathy;Kidney360;2023-03

4. Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy;Blood Cancer Journal;2023-02-27

5. Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies;JACC: CardioOncology;2023-02